These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 25213372)

  • 1. Factors associated with time consumption when answering drug-related queries to Scandinavian drug information centres: a multi-centre study.
    Reppe LA; Spigset O; Böttiger Y; Christensen HR; Kampmann JP; Damkier P; Lydersen S; Schjøtt J
    Eur J Clin Pharmacol; 2014 Nov; 70(11):1395-401. PubMed ID: 25213372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug information centres and their provision of decision support: The Scandinavian experience.
    Schjøtt J; Spigset O
    J Clin Pharm Ther; 2019 Jun; 44(3):489-492. PubMed ID: 30710370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Which factors predict the time spent answering queries to a drug information centre?
    Reppe LA; Spigset O; Schjøtt J
    Pharm World Sci; 2010 Dec; 32(6):799-804. PubMed ID: 20922480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship Between Time Consumption and Quality of Responses to Drug-related Queries: A Study From Seven Drug Information Centers in Scandinavia.
    Amundstuen Reppe L; Lydersen S; Schjøtt J; Damkier P; Rolighed Christensen H; Peter Kampmann J; Böttiger Y; Spigset O
    Clin Ther; 2016 Jul; 38(7):1738-49. PubMed ID: 27368118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current status of pharmacist-operated drug information centers in the United States.
    Rosenberg JM; Koumis T; Nathan JP; Cicero LA; McGuire H
    Am J Health Syst Pharm; 2004 Oct; 61(19):2023-32. PubMed ID: 15509125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacist-operated drug information centers in the United States.
    Rosenberg JM; Fuentes RJ; Starr CH; Kirschenbaum HL; McGuire H
    Am J Health Syst Pharm; 1995 May; 52(9):991-6. PubMed ID: 7641038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of References in Responses from Scandinavian Drug Information Centres.
    Schjøtt J; Böttiger Y; Damkier P; Reppe LA; Kampmann JP; Christensen HR; Spigset O
    Medicines (Basel); 2018 Jul; 5(3):. PubMed ID: 29966383
    [No Abstract]   [Full Text] [Related]  

  • 8. Quality assessment of structure and language elements of written responses given by seven Scandinavian drug information centres.
    Reppe LA; Spigset O; Kampmann JP; Damkier P; Christensen HR; Böttiger Y; Schjøtt J
    Eur J Clin Pharmacol; 2017 May; 73(5):623-631. PubMed ID: 28161750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short communication: pattern of adverse drug reaction related queries received by the drug information centre of a tertiary care teaching hospital.
    Jimmy B; Jose J; Rao PG
    Pak J Pharm Sci; 2007 Oct; 20(4):333-9. PubMed ID: 17604259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survey of drug information centers in the United States-2018.
    Grossman S; Nathan JP; Ipema HJ; Ness GL; Tierno HE; Gabay MP; Calip GS
    Am J Health Syst Pharm; 2020 Jan; 77(1):33-38. PubMed ID: 31743390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. European survey of independent drug information centers.
    Taggiasco N; Sarrut B; Doreau CG
    Ann Pharmacother; 1992 Mar; 26(3):422-8. PubMed ID: 1554964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Challenges in psychopharmacology: a drug information centre perspective.
    Schjøtt J
    J Clin Pharm Ther; 2016 Feb; 41(1):4-6. PubMed ID: 26775691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update on the status of 89 drug information centers in the United States.
    Rosenberg JM; Schilit S; Nathan JP; Zerilli T; McGuire H
    Am J Health Syst Pharm; 2009 Oct; 66(19):1718-22. PubMed ID: 19767377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug information needs of physicians treating diabetic nephropathy in a tertiary care hospital.
    Devi P; George J
    Kathmandu Univ Med J (KUMJ); 2008; 6(1):23-7. PubMed ID: 18604110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug use in pregnancy--physicians' evaluation of quality and clinical impact of drug information centres.
    Frost Widnes SK; Schjøtt J
    Eur J Clin Pharmacol; 2009 Mar; 65(3):303-8. PubMed ID: 19052735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of ten specific questions on nationwide drug information center activity.
    Fisher JM
    Drug Inf J; 1985; 19(1):75-9. PubMed ID: 10270139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of a pilot drug information centre.
    Tumwikirize AW; Ogwal-Okeng JW; Vernby A; Anokbonggo WW; Gustafsson LL; Lundborg CS
    Afr Health Sci; 2011 Sep; 11(3):493-8. PubMed ID: 22275945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical-pharmacological drug information center of Hannover Medical School: experiences and analysis from a tertiary care university hospital.
    Heck J; Stichtenoth DO; Sabau R; Schröder C; Engeli S; Pape T; O'Connell N; Schumacher C; Krause O; Koop F
    Sci Rep; 2022 Nov; 12(1):19409. PubMed ID: 36371467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparing professional and consumer drug information centers.
    Russello CM; Peterson AM
    Am Pharm; 1993 Nov; NS33(11):49-52. PubMed ID: 8249830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of the regional drug information center towards drug safety.
    Palaian S; Mishra P; Shankar PR; Bista D; Purwar B
    JNMA J Nepal Med Assoc; 2006; 45(161):216-8. PubMed ID: 17160101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.